about
Drug-specific upregulation of CD137 on CD8+ T cells aids in the diagnosis of multiple antibiotic toxic epidermal necrolysis.Pneumocystis jirovecii pneumonia following everolimus treatment of metastatic breast cancerThe incubation period of Buruli ulcer (Mycobacterium ulcerans infection).The impact of antimicrobial allergy labels on antimicrobial usage in cancer patientsThe prevalence and impact of antimicrobial allergies and adverse drug reactions at an Australian tertiary centre.Bilateral thigh pain after treatment for prostate cancer.Improving Antimicrobial Stewardship by Antibiotic Allergy Delabeling: Evaluation of Knowledge, Attitude, and Practices Throughout the Emerging Infections Network.Antimicrobial stewardship's new weapon? A review of antibiotic allergy and pathways to 'de-labeling'.The prevention and management of infections due to multidrug resistant organisms in haematology patientsTravel risk assessment, advice and vaccinations in immunocompromised travellers (HIV, solid organ transplant and haematopoeitic stem cell transplant recipients): A review.Testicular loss following bacterial epididymo-orchitis: Case report and literature review.Clinical utility of panfungal polymerase chain reaction for the diagnosis of invasive fungal disease: a single center experience.The 3 Cs of Antibiotic Allergy-Classification, Cross-Reactivity, and Collaboration.Mucormycete infection or colonisation: experience of an Australian tertiary referral centre.Old dog begging for new tricks: current practices and future directions in the diagnosis of delayed antimicrobial hypersensitivity.The epidemiology of Clostridium difficile infection in patients with cancer.Antimicrobial allergy 'labels' drive inappropriate antimicrobial prescribing: lessons for stewardship.Recent advances in the understanding of severe cutaneous adverse reactions.Travel vaccination recommendations and endemic infection risks in solid organ transplantation recipients.Incidence, etiology and timing of infections following azacitidine therapy for myelodysplastic syndromes.The revolving door: antibiotic allergy labelling in a tertiary care centre.Old but not forgotten: Antibiotic allergies in General Medicine (the AGM Study).Taking the Challenge: A Protocolized Approach to Optimize Pneumocystis Pneumonia Prophylaxis in Renal Transplant Recipients.Mycobacterium avium Complex Infection and Immune Reconstitution Inflammatory Syndrome Remain a Challenge in the Era of Effective Antiretroviral Therapy.Penicillin Allergy Is Not Necessarily Forever.Ibrutinib may impair serological responses to influenza vaccination.Impact of an Integrated Antibiotic Allergy Testing Program on Antimicrobial Stewardship: A Multicenter Evaluation.Coxiella burnetii endocarditis after Q fever vaccination.Risks factors and outcomes of Clostridium difficile infection in patients with cancer: a matched case-control study.Return to sender: the need to re-address patient antibiotic allergy labels in Australia and New Zealand.Poor reporting and documentation in drug-associated Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis - Lessons for medication safety.More than skin deep. Ten year follow-up of delayed cutaneous adverse drug reactions (CADR)Oral pristinamycin for the treatment of resistant Gram-positive infections in patients with cancer: Evaluation of clinical outcomes.Australasian Society of Infectious Diseases updated guidelines for the management of Clostridium difficile infection in adults and children in Australia and New Zealand.Putting CYP2C19 genotyping to the test: utility of pharmacogenomic evaluation in a voriconazole-treated haematology cohort.Taming the great: enhanced syphilis screening in HIV-positive men who have sex with men in a hospital clinic setting.A Comparative Analysis Between Antibiotic- and Nonantibiotic-Associated Delayed Cutaneous Adverse Drug Reactions.Non-O1, non-O139 Vibrio cholerae bacteraemia in an Australian population.Disseminated Scedosporium prolificans infection in an 'extensive metaboliser': navigating the minefield of drug interactions and pharmacogenomics.Faecal microbiota transplantation for severe Clostridium difficile infection in the intensive care unit.
P50
Q33703420-DF846834-FD72-498B-8FB7-D4C184A8053AQ34436156-47FE4F62-8669-4E47-910A-A2D090F4B216Q35010447-18A8C90D-B7EB-4B0D-8F4F-7F471001F7E0Q35669611-DD451884-D08F-49DB-AE08-67E8764AA4E5Q35870947-A74A9B13-8E2E-42B9-B423-649EE8322CF3Q36746100-B5A079F9-71CE-4510-971D-6BEF8D0582F6Q37375419-DFCCE01D-209D-4E23-8DD3-10F78F7FDEA8Q37389754-1AD48B21-EF72-4AC5-9A3A-B2E8E87B93CCQ38171538-E2739A9D-8287-49EA-AB77-4FE159AF9593Q38320135-9FC7F8C6-68C6-43B1-BAA4-D35A75852967Q38406721-A8390067-C262-417C-9BAA-BA297C51891EQ38623150-FA1E6BE3-B6F1-4DE3-8D0B-45EF392486BCQ38637036-8B84D5AE-8308-4252-BB7E-A56818015F95Q38726670-4914C27B-281B-47BC-867B-5914883B2F9BQ38805641-2F0B658B-52F6-40A4-B848-6E7E2069761BQ38823326-8D44791A-0042-4DE3-AD34-70205B00E728Q38905769-985BACDC-91F5-4C21-92A6-9463B41E9B1BQ38931289-FC067E23-9348-4C81-BC92-C37AFC24C606Q38953830-FEB1870F-546A-4020-B7FA-3D7C71E29DE9Q39171248-B5E65F7C-9B31-4ED2-8562-9247EBCFFE56Q39484758-A1117B00-69DF-45F3-89AC-220C0461827DQ39850905-F8D81D7E-9B3E-462C-8798-6398B7F5AC36Q40051231-44683947-73FA-4EEF-A71C-CE47728AF35AQ40100782-90CA9C47-CA31-43C2-9094-29D1FED0B4FDQ40149092-3A9FDF6A-E76D-4A26-880F-5A8FDBA3B76BQ40154480-74F189B7-B5A1-462F-B98F-9055CE531F79Q40207596-9F70C475-36E5-457D-9848-0D2EBC0BE7EBQ40275160-58A12D79-8DF8-4FB0-A405-7BCAFE47919FQ40347744-D472D020-0298-4BF8-B658-7CC518235D45Q40467164-7D16EF12-F9FB-4AB6-BA7B-5789BD9EB339Q40563771-3D42058A-F760-4C7A-9CA1-4029BD1608FDQ40644493-DBC0B4D4-ECCD-482E-AC34-2C25D2643C76Q40709860-0A6A2B40-81CB-42E7-9F26-2C8D00374855Q40721471-09659BD2-4F94-4A5D-8465-4AC767F14AABQ41564182-34E0F880-3254-4BFB-9818-00AA49EBF022Q41589090-3F5579A9-11D9-46CC-A6F9-B8EE1612A742Q42104253-CC7C9814-E993-4F13-9BF4-C15EBD3CB03FQ42215790-4E9768C3-BD82-4FDE-B6E0-CB7002241F00Q42218014-069F88A3-AC80-452F-8754-4383D06A4ADCQ42288009-9DBD5FC1-24EE-46DB-A055-2DAEDC7D34D5
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
J Trubiano
@ast
J Trubiano
@en
J Trubiano
@es
J Trubiano
@nl
J Trubiano
@sl
type
label
J Trubiano
@ast
J Trubiano
@en
J Trubiano
@es
J Trubiano
@nl
J Trubiano
@sl
prefLabel
J Trubiano
@ast
J Trubiano
@en
J Trubiano
@es
J Trubiano
@nl
J Trubiano
@sl
P106
P1153
55443852400
P31
P496
0000-0002-5111-6367